Bioalpha Holdings Berhad Past Earnings Performance
Past criteria checks 0/6
Bioalpha Holdings Berhad's earnings have been declining at an average annual rate of -53.6%, while the Personal Products industry saw earnings growing at 8.9% annually. Revenues have been declining at an average rate of 7.8% per year.
Key information
-53.6%
Earnings growth rate
-49.7%
EPS growth rate
| Personal Products Industry Growth | 8.3% |
| Revenue growth rate | -7.8% |
| Return on equity | -30.0% |
| Net Margin | -83.6% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) A Risky Investment?
Mar 19
Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?
Oct 04Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) Using Debt Sensibly?
Jun 20Bioalpha Holdings Berhad (KLSE:BIOHLDG) Is Using Debt Safely
Mar 01Why Bioalpha Holdings Berhad (KLSE:BIOHLDG) Could Be Worth Watching
Mar 29Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?
Mar 03Can You Imagine How Bioalpha Holdings Berhad's (KLSE:BIOHLDG) Shareholders Feel About The 42% Share Price Increase?
Jan 20
How Much Is Bioalpha Holdings Berhad's (KLSE:BIOHLDG) CEO Getting Paid?
Nov 28Revenue & Expenses BreakdownBeta
How Bioalpha Holdings Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 46 | -39 | 27 | 0 |
| 30 Sep 23 | 40 | -52 | 33 | 0 |
| 30 Jun 23 | 35 | -56 | 33 | 0 |
| 31 Mar 23 | 35 | -61 | 33 | 0 |
| 31 Dec 22 | 36 | -48 | 32 | 0 |
| 30 Sep 22 | 38 | -24 | 21 | 0 |
| 30 Jun 22 | 59 | -16 | 20 | 0 |
| 31 Mar 22 | 82 | -7 | 19 | 0 |
| 31 Dec 21 | 97 | -1 | 19 | 0 |
| 30 Sep 21 | 100 | -13 | 16 | 0 |
| 30 Jun 21 | 78 | -25 | 19 | 0 |
| 31 Mar 21 | 55 | -34 | 22 | 0 |
| 31 Dec 20 | 36 | -41 | 23 | 0 |
| 30 Sep 20 | 40 | -22 | 26 | 0 |
| 30 Jun 20 | 50 | -8 | 22 | 0 |
| 31 Mar 20 | 58 | 2 | 19 | 0 |
| 31 Dec 19 | 64 | 8 | 18 | 0 |
| 30 Sep 19 | 62 | 9 | 16 | 0 |
| 30 Jun 19 | 65 | 10 | 17 | 0 |
| 31 Mar 19 | 70 | 12 | 18 | 0 |
| 31 Dec 18 | 70 | 12 | 19 | 0 |
| 30 Sep 18 | 72 | 13 | 20 | 0 |
| 30 Jun 18 | 66 | 12 | 19 | 0 |
| 31 Mar 18 | 60 | 10 | 19 | 0 |
| 31 Dec 17 | 56 | 8 | 21 | 0 |
| 30 Sep 17 | 52 | 8 | 21 | 0 |
| 30 Jun 17 | 50 | 7 | 22 | 0 |
| 31 Mar 17 | 49 | 6 | 21 | 0 |
| 31 Dec 16 | 47 | 8 | 19 | 0 |
| 30 Sep 16 | 41 | 8 | 19 | 0 |
| 30 Jun 16 | 37 | 8 | 16 | 0 |
| 31 Mar 16 | 33 | 7 | 14 | 0 |
| 31 Dec 15 | 30 | 7 | 12 | 0 |
| 30 Sep 15 | 28 | 6 | 7 | 0 |
| 30 Jun 15 | 28 | 5 | 10 | 0 |
| 31 Mar 15 | 28 | 7 | 10 | 0 |
| 31 Dec 14 | 27 | 6 | 11 | 0 |
| 31 Dec 13 | 25 | 6 | 5 | 0 |
Quality Earnings: BIOHLDG is currently unprofitable.
Growing Profit Margin: BIOHLDG is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BIOHLDG is unprofitable, and losses have increased over the past 5 years at a rate of 53.6% per year.
Accelerating Growth: Unable to compare BIOHLDG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BIOHLDG is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (18%).
Return on Equity
High ROE: BIOHLDG has a negative Return on Equity (-29.99%), as it is currently unprofitable.